Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Novozymes Biotechnology ApS
APS
Dissolved
CVR 42790877
Krogshøjvej 36
Leasing of intellectual property and similar products, except copyrighted works · NACE 7740
Est. 2021
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2021
DKK -25K
EBITDA margin
100.0%
Equity ratio
78.0%
Financial strength
Net profit 2021
DKK -2,2M
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
Key figures
Annual report 2021
Revenue
DKK -25K
—
EBITDA
DKK -25K
—
Net profit
DKK -2,2M
—
Total assets
DKK 237,5M
—
Equity
DKK 185,3M
—
Employees
—
—
Company information
Legal name
Novozymes Biotechnology ApS
CVR number
42790877
Legal form
Anpartsselskab
NACE code
7740 · Leasing of intellectual property and similar products, except copyrighted works
Founded
28. oktober 2021
Share capital
DKK 1.000.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller et bestyrelsesmedlem alene.
Contact
Address
Krogshøjvej 36
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Leasing of intellectual property and similar products, except copyrighted works
Companies in Gladsaxe
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
Income statement
DKK thousands
Item
2021
Revenue
-25
Staff expenses
-0
EBITDA
-25
Depreciation & amort.
-2.667
EBIT
-2.692
Net financials
-148
Profit before tax
-2.839
Tax
-625
Net profit
-2.215
Balance sheet
DKK thousands
Item
2021
Total assets
237.524
Equity
185.285
Long-term debt
0
Short-term debt
25
Total debt
25
Financial ratios
5-year trend
EBITDA margin
-2500000.0%
This company
15.8%
Market median
-15822885% vs market
2021
2021
Equity ratio
78.0%
This company
38.2%
Market median
+104% vs market
2021
2021
Return on equity
-1.2%
This company
18.4%
Market median
-107% vs market
2021
2021
Net profit margin
-221458800.0%
This company
8.1%
Market median
-2734059359% vs market
2021
2021
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2021
2021
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
2021
2021
Annual reports & filings
Annual report 2021
Filed via CVR / Virk · Period 2021-10-28 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
RC
Randi Camilla Kinch Jensen
Chief Executive Officer
Chief Executive Officer
2021 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
LG
Lars Green
Board of Directors
2021 – 2022
MV
Mikkel Viltoft
Chairman
2021 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
NOVOZYMES A/S
Company
100%
100%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Novozymes Biotechnology ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Randi Camilla Kinch Jensen
Chief Executive Officer
0 companies
Lars Green
Board of Directors
0 companies
Mikkel Viltoft
Chairman
0 companies